COMPARISON BETWEEN ULTRASOUND GUIDED TRU-CUT BIOPSY AND NON-ULTRASOUND GUIDED TRU-CUT BIOPSY IN THE DIAGNOSIS OF BREAST MASS CONFIRMED BY OPEN SURGICAL BIOPSY

Abstract

Of all breast issues, benign breast illness is by far the most common. Approximately one-third of women will experience some sort of benign breast issue that necessitates treatment. This is particularly true when the symptoms start to negatively impact the woman's mental health. A lump, soreness, or both are the most prevalent signs. Before surgery, the triple evaluation was the gold standard for non-surgical breast lump identification; it also helps determine whether a patient with breast cancer will benefit from conservative or neo-adjuvant therapy options. In recent years, the revised Triple Assessment has surpassed its predecessor as the gold standard in diagnostics. Not only that, but ultrasound-guided Tru-cut biopsy is less expensive and more effective than surgical biopsy and stereotactic guidance. The good safety profile of this approach makes it preferred for obtaining biopsies from worrisome non-palpable breast lesions revealed by ultrasonography. .Method One hundred women with breast lumps visited the breast clinics at Al-Kindy teaching hospital and Baghdad teaching hospital (oncology center) in Baghdad between June 1, 2018, and October 1, 2020, for this cross-sectional study. We used a pre-made algorithm to compile all of the patient data, which included age, lump location (right or left), and BIRADS ultrasound results. The first group consists of 50 patients who received Tru-cut needle biopsy without ultrasound guidance, while the second group consists of 50 instances that underwent Tru-cut needle biopsy with ultrasound guidance. According to their histology findings, patients underwent surgical procedures; the most advanced cases received treatment first. Result The breast clinic saw one hundred ladies who were dealing with breast lumps. The average age of the 74 individuals with malignant lesions was 47.19 years. Of the 26 cases, 34.9±11.5 years were associated with benign lesions. Among malignant lesions, ductal carcinoma ranks first with 66 cases, whereas among benign lesions, fibroadenoma ranks first with 17 cases. With a Sen=90.1% and a spec=100, the agreement between the open biopsy and the Tru-cut biopsy in the first group was 0.840, and the p-value was 0.001. In contrast, the second group achieved a Sen=97.6%, spec=100 agreement with a p-value of 0.001. Conclusion Based on these findings, we recommend using ultrasound-guided Tru-cut biopsies to diagnose any abnormality in the breast, whether it is palpable or impalpable (seen only by ultrasound). For the treatment of any breast issue, we must adhere to the guidelines of the modified triple evaluation. Aim of the Study The purpose of this study is to assess the ultrasound-guided Tru-cut biopsy for breast mass detection in terms of its sensitivity, specificity, accuracy, utility, and function.